Pregled bibliografske jedinice broj: 684999
Trastuzumab-induced cardiotoxicity
Trastuzumab-induced cardiotoxicity // 20th ICACT International Congress On Anti-Cancer Treatment, Pariz 2009., Abstracts book
Pariz, Francuska, 2009. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 684999 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Trastuzumab-induced cardiotoxicity
Autori
Vazdar, Ljubica ; Mršić-Krmpotić, Zrinka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
20th ICACT International Congress On Anti-Cancer Treatment, Pariz 2009., Abstracts book
/ - , 2009
Skup
International Congress On Anti-Cancer Treatment
Mjesto i datum
Pariz, Francuska, 03.02.2009. - 06.02.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
trastuzumab; cardiotoxicity
Sažetak
Cardiotoxicity is a serious side effect of trastuzumab, the humanized monoclonal antibody which is the gold standard in the treatment of early and metastatic breast cancer. In our study followed 171 women with breast cancer (126 early breast cancer and 45 metastatic breast cancer). Symptomatic systolic heart failure was found in 3.2% of women treated with adjuvant and 5.2% in metastatic treatment. Risk factors for the development of trastuzumab-induced cardiotoxicity were basal left ventricular ejection fraction and older age.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore
